An autopsy study of the spectrum of severe COVID-19 in children: From SARS to different phenotypes of MIS-C

Carregando...
Imagem de Miniatura
Citações na Scopus
88
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER
Citação
ECLINICALMEDICINE, v.35, article ID 100850, 13p, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: COVID-19 in children is usually mild or asymptomatic, but severe and fatal paediatric cases have been described. The pathology of COVID-19 in children is not known; the proposed pathogenesis for severe cases includes immune-mediated mechanisms or the direct effect of SARS-CoV-2 on tissues. We describe the autopsy findings in five cases of paediatric COVID-19 and provide mechanistic insight into the mechanisms involved in the pathogenesis of the disease. Methods: Children and adolescents who died with COVID-19 between March 18 and August 15, 2020 were autopsied with a minimally invasive method. Tissue samples from all vital organs were analysed by histology, electron microscopy (EM), reverse-transcription polymerase chain reaction (RT-PCR) and immunohistochemistry (IHC). Findings: Five patients were included, one male and four female, aged 7 months to 15 years. Two patients had severe diseases before SARS-CoV-2 infection: adrenal carcinoma and Edwards syndrome. Three patients were previously healthy and had multisystem inflammatory syndrome in children (MIS-C) with distinct clinical presentations: myocarditis, colitis, and acute encephalopathy with status epilepticus. Autopsy findings varied amongst patients and included mild to severe COVID-19 pneumonia, pulmonary microthrombosis, cerebral oedema with reactive gliosis, myocarditis, intestinal inflammation, and haemophagocytosis. SARSCoV-2 was detected in all patients in lungs, heart and kidneys by at least one method (RT-PCR, IHC or EM), and in endothelial cells from heart and brain in two patients with MIS-C (IHC). In addition, we show for the first time the presence of SARS-CoV-2 in the brain tissue of a child with MIS-C with acute encephalopathy, and in the intestinal tissue of a child with acute colitis. Interpretation: SARS-CoV-2 can infect several cell and tissue types in paediatric patients, and the target organ for the clinical manifestation varies amongst individuals. Two major patterns of severe COVID-19 were observed: a primarily pulmonary disease, with severe acute respiratory disease and diffuse alveolar damage, or a multisystem inflammatory syndrome with the involvement of several organs. The presence of SARS-CoV-2 in several organs, associated with cellular ultrastructural changes, reinforces the hypothesis that a direct effect of SARS-CoV-2 on tissues is involved in the pathogenesis of MIS-C. (c) 2021 The Author(s).
Palavras-chave
Covid-19, Sars-cov-2, Autopsy, Pathology, Minimally invasive autopsy, Children, MIS-C, multisystem inflammatory syndrome in children
Referências
  1. Abdel-Mannan O, 2020, JAMA NEUROL, V77, P1440, DOI 10.1001/jamaneurol.2020.2687
  2. Ahmed M, 2020, ECLINICALMEDICINE, V26, DOI 10.1016/j.eclinm.2020.100527
  3. Baud D, 2020, JAMA-J AM MED ASSOC, V323, P2198, DOI 10.1001/jama.2020.7233
  4. Belhadjer Z, 2020, CIRCULATION, V142, P429, DOI 10.1161/CIRCULATIONAHA.120.048360
  5. Bixler D, 2020, MMWR-MORBID MORTAL W, V69, P1324, DOI 10.15585/mmwr.mm6937e4
  6. Centers for Disease Control and Prevention Emergency Preparedness and Response, MULT INFL SYNDR CHIL MULT INFL SYNDR CHIL
  7. Centers for Disease Control and Prevention-Coronavirus Disease 2019 (COVID- 19), INT GUID COLL HANDL
  8. Chan KH, 2020, J HOSP INFECT, V106, P226, DOI 10.1016/j.jhin.2020.07.009
  9. Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
  10. Craver R, 2020, FETAL PEDIATR PATHOL, V39, P263, DOI 10.1080/15513815.2020.1761491
  11. Dhochak N, 2020, INDIAN J PEDIATR, V87, P537, DOI 10.1007/s12098-020-03322-y
  12. Dolhnikoff M, 2020, LANCET CHILD ADOLESC, V4, P790, DOI 10.1016/S2352-4642(20)30257-1
  13. Dolhnikoff M, 2020, J THROMB HAEMOST, V18, P1517, DOI 10.1111/jth.14844
  14. Duarte-Neto AN, 2020, HISTOPATHOLOGY, V77, P186, DOI 10.1111/his.14160
  15. Dufort EM, 2020, NEW ENGL J MED, V383, P347, DOI 10.1056/NEJMoa2021756
  16. Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680
  17. Gnecchi M, 2020, LANCET, V395, pE116, DOI 10.1016/S0140-6736(20)31307-6
  18. Gotzinger F, 2020, LANCET CHILD ADOLESC, V4, P653, DOI 10.1016/S2352-4642(20)30177-2
  19. Goshua G, 2020, LANCET HAEMATOL, V7, pE575, DOI 10.1016/S2352-3026(20)30216-7
  20. Grimaud M, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00690-8
  21. Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
  22. Leon-Abarca JA, 2020, PEDIATR OBES, V15, DOI 10.1111/ijpo.12713
  23. Levi M, 2017, THROMB RES, V149, P38, DOI 10.1016/j.thromres.2016.11.007
  24. Levin M, 2020, NEW ENGL J MED, V383, P393, DOI 10.1056/NEJMe2023158
  25. Liguoro I, 2020, EUR J PEDIATR, V179, P1029, DOI 10.1007/s00431-020-03684-7
  26. Lopez L, 2010, J AM SOC ECHOCARDIOG, V23, P465, DOI 10.1016/j.echo.2010.03.019
  27. Matschke J, 2020, LANCET NEUROL, V19, P919, DOI 10.1016/S1474-4422(20)30308-2
  28. McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484
  29. Ministerio ~ da Saude- ~Secretaria de Vigil^ancia em Saude, B EP ESP SEM EP
  30. Rimensberger PC, 2021, PEDIATR CRIT CARE ME, V22, P56, DOI 10.1097/PCC.0000000000002599
  31. Sahn B, 2021, J PEDIATR GASTR NUTR, V72, P384, DOI 10.1097/MPG.0000000000002953
  32. Schuler BA, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI140766
  33. Schurink B, 2020, LANCET MICROBE, V1, pE290, DOI 10.1016/S2666-5247(20)30144-0
  34. Sonzogni A, 2020, LIVER INT, V40, P2110, DOI 10.1111/liv.14601
  35. Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2
  36. Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003
  37. Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
  38. WHO, 2020, MULT INFL SYNDR CHIL
  39. Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
  40. Zachariah P, 2020, JAMA PEDIATR, V174, DOI 10.1001/jamapediatrics.2020.2430